Pubertal Suppression in Transgender Youth
Seiten
2018
Elsevier - Health Sciences Division (Verlag)
978-0-323-56963-7 (ISBN)
Elsevier - Health Sciences Division (Verlag)
978-0-323-56963-7 (ISBN)
Offering current guidelines on the relatively new practice of puberty suppression for gender-dysphoric adolescents, Pubertal Suppression in Transgender Youth provides a succinct, easy-to-digest overview of this timely topic. This concise, clinically-focused resource by Dr. Courtney Finlayson covers all relevant topics, from a brief history of medical care of transgender youth to emerging developments in the field.
Covers the use of gonadotropin-releasing hormone agonist (GnRHa) therapy in transgender youth, including models of care and current treatment guidelines, fertility issues, ethical considerations and the consent process, and more.
Discusses psychosocial, medical, and surgical side effects of treatment.
Consolidates today's available information on this timely topic into one convenient resource.
Covers the use of gonadotropin-releasing hormone agonist (GnRHa) therapy in transgender youth, including models of care and current treatment guidelines, fertility issues, ethical considerations and the consent process, and more.
Discusses psychosocial, medical, and surgical side effects of treatment.
Consolidates today's available information on this timely topic into one convenient resource.
1. History of Transgender Care of Youth 2. Models of Care and Current Guidelines for Care of Transgender Individuals
3. Puberty (a review of normal pubertal physiology and development)
4. GnRH agonists (mechanism, past studies, use in precocious puberty, drug options, surgical placement)
5. GnRHa for gender non-conformng youth (Rationale for, Studies of efficacy, Initiation and monitoring of GnRHa)
6. Psychosocial Side Effects of GnRHa
7. Medical Side Effects of GnRHa
8. Surgical Side Effects of GnRHa
9. Fertility and GnRHa treatment
10. Treatment with GnRH Agonists and Gender Affirming Hormones
11. Ethical considerations of GnRHa treatment and consent process
12. Emerging Developments
Erscheinungsdatum | 19.09.2018 |
---|---|
Verlagsort | Philadelphia |
Sprache | englisch |
Maße | 191 x 235 mm |
Gewicht | 230 g |
Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Endokrinologie |
ISBN-10 | 0-323-56963-3 / 0323569633 |
ISBN-13 | 978-0-323-56963-7 / 9780323569637 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Buch | Hardcover (2023)
UNI-MED (Verlag)
CHF 55,70